Literature DB >> 4190916

Prediction of the long-term results of antithyroid drug therapy for thyrotoxicosis.

W D Alexander, D G McLarty, J Robertson, J Shimmins, B E Brownlie, R M Harden, A R Patel.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1970        PMID： 4190916     DOI： 10.1210/jcem-30-4-540

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN： 0021-972X            Impact factor:   5.958


× No keyword cloud information.
  10 in total

1.  Tests of thyroid function in vivo.

Authors:  A W Goolden
Journal:  J Clin Pathol       Date:  1975-03       Impact factor: 3.411

2.  Response to TRH, serum thyroid hormone concentration, and serum markers of autoimmunity after antithyroid therapy in Graves' disease.

Authors:  B A Lamberg; A Aro; P Saarinen; T Tötterman; T Mäkinen
Journal:  J Endocrinol Invest       Date:  1978-01       Impact factor: 4.256

3.  [Current status of diagnosis in thyroid diseases].

Authors:  P M Reisert
Journal:  Arch Klin Exp Ohren Nasen Kehlkopfheilkd       Date:  1972

4.  Editorial: Hyperthyroidism.

Authors:  J P Kriss
Journal:  Calif Med       Date:  1970-08

5.  Time and tides in Graves's disease: their implications in predicting outcome of treatment.

Authors:  T J Wilkin; J S Beck; J Crooks; T E Isles; A Gunn
Journal:  Br Med J       Date:  1979-01-13

6.  Simple and reliable method for predicting the remission of Graves' disease: revised triiodothyronine-suppression test, indexed by serum thyroxine.

Authors:  N Takasu; H Akamine; I Komiya; T Yamada
Journal:  J Endocrinol Invest       Date:  1995-04       Impact factor: 4.256

Review 7.  Appropriate duration of antithyroid drug treatment as a predictor for relapse of Graves' disease: a systematic scoping review.

Authors:  F Azizi; H Abdi; L Mehran; A Amouzegar
Journal:  J Endocrinol Invest       Date:  2022-01-28       Impact factor: 4.256

8.  Thyrotoxicosis: changing trends in treatment.

Authors:  J Sheldon; D J Reid
Journal:  Ann R Coll Surg Engl       Date:  1986-09       Impact factor: 1.891

9.  Thyroid stimulating immunoglobulin bioactivity during carbimazole therapy as measured by the cytochemical bioassay.

Authors:  M G Prentice; G A Rayman; J Alaghband-Zadeh; P H Wise
Journal:  J Endocrinol Invest       Date:  1987-10       Impact factor: 4.256

Review 10.  The impact of peptide hormone receptor research on clinical medicine.

Authors:  T F Davies
Journal:  J R Coll Physicians Lond       Date:  1978-07
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.